Bringing 3 Significant Events Under 1 Roof!

The Pharmaceutical Congress China, part of IBC’s PharmaCon Series, recognizes the importance of regulation, clinical operation efficiencies, tackling pharmaceutical compliance issues and bringing products and services successfully in the market in China’s rapidly advancing pharmaceutical industry.

  Navigate through a complex R&D environment

  Seek clarity on pharmaceutical regulations and drug approvals in       China

  Ensure your organization is operating compliantly

Featured Speakers

Li Chen
CEO, Hua Medicine, China

Xian Ping Lu
CEO, Shenzhen Chipscreen Biosciences, China

Ye Hua
Senior Vice President, Clinical Development and Regulatory Affairs, Hutchison Medipharma, China

Weikang Tao
CEO, R&D Centre, Shanghai Hengrui Medicine, China

Ming-Qiang Zhang
Corporate Vice-President, Research & Development, Amgen, China

Ming-Chu Hsu
Chairman of the Board & CEO, TaiGen Biotechnology, Taiwan

Joan Shen
Vice President, Development Head China R&D and Scientific Affairs, Janssen Pharmaceuticals, China

Friedhelm Blobel
CEO, SciClone Pharmaceuticals, USA & China

Dan Paulson
Vice President, Global Clinical Development, Group Head, Cardiometabolism Risk Management and Antiinfectives, Bayer HealthCare Pharmaceuticals, China

Christina Bodurow
Senior Director, External Sourcing, Development Center of Excellence, Eli Lilly and Co, USA

View all speakers »

Hear Our Past Reviews

Comprehensive conference covered most areas concerned by pharmaceutics, CRO and clinical trial centers in China. Different from clinical trial event, which often focus on one or two aspects of clinical trial.

Director, Clinical Operations, TenNor Therapeutics
A very diverse panel of speakers and attendees.

CEO, BARC Central Labs
This is a very worthwhile conference. In addition to the sessions, there are networking breaks that allow interaction between attendees at one of three sessions that take place concurrently.

Director, Clinical Development and Medical Affairs, Respiratory Therapeutic Area, Boehringer Ingelheim Pharmaceuticals
I found the meeting quite robust and certainly had a good and healthy exchange of knowledge. I would certainly be happy to participate in future initiatives and explore how these great meetings can be made more interactive and rewarding.

Regional Medical Leader, Oncology, Asia Pacific Medical Affairs, Roche Pharmaceuticals
Thank you for providing the platform which allows all experts to exchange and discuss thoughtful viewpoint inside of clinical trials industry. Your organization always impresses me.

Vice Chairman, Asia Pacific, PAREXEL International

About the conference »

Contact Us

Produced by

Supporting Associations

Gold Sponsor

Bronze Sponsor

Associate SponsorSession Spotlight Sponsor


Media Partners



International Marketing Partner